A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development
Abstract Adverse drug reactions (ADRs) of targeted therapy drugs (TTDs) are frequently unexpected and long‐term toxicities detract from exceptional efficacy of new TTDs. In this proof‐of‐concept study, we explored how molecular causation involved in trastuzumab‐induced cardiotoxicity changes when tr...
Saved in:
Main Authors: | Sarah Kim (Author), Gezim Lahu (Author), Majid Vakilynejad (Author), Theodoros G. Soldatos (Author), David B. Jackson (Author), Lawrence J. Lesko (Author), Mirjam N. Trame (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
by: Sarah Kim, et al.
Published: (2022) -
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
by: Theodoros G. Soldatos, et al.
Published: (2022) -
Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar
by: Christos Sachpekidis, et al.
Published: (2019) -
Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies
by: Wei Yin, et al.
Published: (2024) -
Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults
by: Wei Yin, et al.
Published: (2023)